 |
인쇄하기
취소
|
Handok to launch combined anti-diabetic drug.
Handok has launched Amaryl-M, a combined anti-diabetic drug with Amaryl (glimepiride) and metformin, which boosts to simulate Insulin secretion and at the same time to enhance an Insulin sensitivity.
Two dosage forms are introduced, namely, Amaryl M 1/250 (1mg of glimepiride plus metformin 250mg) and Amaryl M 2/250 (2mg of glimepride plus metformin 250mg).
The combined therapy has been cl...
Two dosage forms are introduced, namely, Amaryl M 1/250 (1mg of glimepiride plus metformin 250mg) and Amaryl M 2/250 (2mg of glimepride plus metformin 250mg).
The combined therapy has been cl...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.